相关实验视频

Updated: Jul 23, 2025

Probiotic Studies in Neonatal Mice Using Gavage

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

在英国新生儿病房中,常规使用益生菌的频率有多高?

Neaha Patel¹, , Katie Evans²

¹Department of Neonatology, Homerton Healthcare NHS Foundation Trust, London, UK.

BMJ paediatrics open

|July 14, 2023

概括

现在,超过40%的英国新生儿病房经常给早产婴儿服用益生菌,但产品选择各不相同. 需要进一步的研究来确认这种增加的益生菌使用是否改善了临床结果.

科学领域:

新生儿医学新生儿医学
微生物学微生物学
临床药房临床药房

背景情况:

英国缺乏针对早产婴儿常规使用益生菌的指导意见,以防止死性肠球炎,晚发性败血症和死亡.
目前在英国新生儿病房中使用益生菌的做法有所变化.

研究的目的:

为了确定目前的益生菌在英国新生儿单位的使用模式.
为了确定特定的益生菌产品,使用的管理方案和相关指导方针.

主要方法:

在2022年通过实习生领导的NeoTRIPS网络向英格兰,苏格兰,北爱尔兰和威尔士的新生儿单位分发了一项在线调查.
这项调查收集了对早产婴儿常规使用益生菌的数据,包括产品类型,妊娠年龄标准和停药协议.

主要成果:

在接受调查的新生儿医疗单位中,有86%的新生儿反应良好,其中44%的新生儿经常给早产婴儿服用益生菌.
使用最常见的益生菌产品是Lactobacillus acidophilus NCFM/Bifidobacterium bifidum Bb-06/B. 最常见的益生菌产品是Lactobacillus acidophilus NCFM/Bifidobacterium bifidum Bb-06/B. 这两种类型的益生菌. 婴儿生物-26 (LabinicTM) 类药物. 婴儿生物-26 (LabinicTM) 类药物.
大多数单位在孕期 ≤32周的婴儿中开始服用益生菌,需要肠道养,如果养被扣留或在死角性肠球炎治疗期间停止服用益生菌.

结论:

现在,超过40%的英国新生儿病房在早产婴儿中经常使用益生菌,产品选择的差异很大.
益生菌的越来越多的使用凸显了进一步研究的必要性,以确定这些做法是否会改善临床结果.

关键词:

微生物学的微生物.新生儿科学新生儿科学

更多相关视频

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Novel Production Protocol for Small-scale Manufacture of Probiotic Fermented Foods

Published on: September 10, 2016

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

相关概念视频

Healthcare Associated Infections II: Preventive Measures

Healthcare Associated Infections II: Preventive Measures

Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.